Cargando…

Targeting macrophagic 17β-HSD7 by fenretinide for the treatment of nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide and macrophage polarization plays an important role in its pathogenesis. However, which molecule regulates macrophage polarization in NAFLD remains unclear. Herein, we showed NAFLD mice exhibited increased 17...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Xiaoyu, Feng, Yiting, Xu, Dongqin, Zhang, Mengya, Wen, Xiao, Zhao, Wenhao, Hu, Qintong, Zhang, Qinyong, Fu, Hui, Ping, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939369/ https://www.ncbi.nlm.nih.gov/pubmed/36815031 http://dx.doi.org/10.1016/j.apsb.2022.04.003

Ejemplares similares

Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis
por: Luukkonen, Panu K., et al.
Publicado: (2023)

Macrophage metabolism in nonalcoholic fatty liver disease
por: Zhang, Wenhui, et al.
Publicado: (2023)

Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms
por: Bellan, Mattia, et al.
Publicado: (2019)

Fenretinide-induced apoptosis of Huh-7 hepatocellular carcinoma is retinoic acid receptor β dependent
por: Bu, Pengli, et al.
Publicado: (2007)

Male 11β-HSD1 Knockout Mice Fed Trans-Fats and Fructose Are Not Protected From Metabolic Syndrome or Nonalcoholic Fatty Liver Disease
por: Larner, Dean P., et al.
Publicado: (2016)

Macrophage 11β-HSD-1 deficiency promotes inflammatory angiogenesis
por: Zhang, Zhenguang, et al.
Publicado: (2017)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Hydroxybenzothiazoles as New Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1)
por: Spadaro, Alessandro, et al.
Publicado: (2012)

Pediatric non-alcoholic fatty liver disease and kidney function: Effect of HSD17B13 variant
por: Di Sessa, Anna, et al.
Publicado: (2020)

Fenretinide Inhibits Neutrophil Recruitment and IL-1β Production in Aspergillus fumigatus Keratitis
por: Zhao, Wenyi, et al.
Publicado: (2018)

Phosphorylation of 17β-hydroxysteroid dehydrogenase 13 at serine 33 attenuates nonalcoholic fatty liver disease in mice
por: Su, Wen, et al.
Publicado: (2022)

The protective effect of fenretinide against allergic asthma
por: Kanagaratham, Cynthia, et al.
Publicado: (2010)

Fenretinide: A Novel Treatment for Endometrial Cancer
por: Mittal, Navdha, et al.
Publicado: (2014)

Fenretinide regulates macrophage polarization to protect against experimental colitis induced by dextran sulfate sodium
por: Cao, Yong, et al.
Publicado: (2020)

Fenretinide Corrects the Imbalance between Omega-6 to Omega-3 Polyunsaturated Fatty Acids and Inhibits Macrophage Inflammatory Mediators via the ERK Pathway
por: Lachance, Claude, et al.
Publicado: (2013)

Functional genetic variant of HSD17B12 in the fatty acid biosynthesis pathway predicts the outcome of colorectal cancer
por: Lin, Yu, et al.
Publicado: (2020)

HSD17B13: A Potential Therapeutic Target for NAFLD
por: Zhang, Hai-bo, et al.
Publicado: (2022)

Fenretinide Improves Intestinal Barrier Function and Mitigates Alcohol Liver Disease
por: Tang, Xiao-Han, et al.
Publicado: (2021)

Insights in 17β-HSD1 Enzyme Kinetics and Ligand Binding by Dynamic Motion Investigation
por: Negri, Matthias, et al.
Publicado: (2010)

THU574 Hsd17b1 Partially Compensates For The Lack Of Hsd17b3 In Testicular Testosterone Production In Fetal Mice, But Not In Adults
por: Poutanen, Matti, et al.
Publicado: (2023)

Fenretinide Acts as Potent Radiosensitizer for Treatment of Rhabdomyosarcoma Cells
por: Brack, Eva, et al.
Publicado: (2021)

Preparation and Characterization of Amorphous Solid Dispersions for the Solubilization of Fenretinide
por: Zuccari, Guendalina, et al.
Publicado: (2023)

Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR(−/−) mice
por: Thompson, Dawn, et al.
Publicado: (2023)

Ovarian and Breast Cancer Spheres Are Similar in Transcriptomic Features and Sensitive to Fenretinide
por: Wang, Haiwei, et al.
Publicado: (2013)

IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice
por: Harley, Isaac TW, et al.
Publicado: (2014)

Synthesis of substituted 15β-alkoxy estrone derivatives and their cofactor-dependent inhibitory effect on 17β-HSD1
por: Herman, Bianka Edina, et al.
Publicado: (2019)

The Mitochondrial Enzyme 17βHSD10 Modulates Ischemic and Amyloid-β-Induced Stress in Primary Mouse Astrocytes
por: Metodieva, Vanya, et al.
Publicado: (2022)

SUN-213 Hsd17b3 Knockout Mice Serve As A Model To Define Mechanisms Behind The Altered Endocrine Phenotype Of Patients With Hsd17b3 Mutations
por: Poutanen, Matti, et al.
Publicado: (2019)

Structural Basis for Species Specific Inhibition of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1): Computational Study and Biological Validation
por: Klein, Tobias, et al.
Publicado: (2011)

11β-HSD1 Inhibitor Alleviates Non-Alcoholic Fatty Liver Disease by Activating the AMPK/SIRT1 Signaling Pathway
por: Chen, Ying, et al.
Publicado: (2022)

Impact of 17β-HSD12, the 3-ketoacyl-CoA reductase of long-chain fatty acid synthesis, on breast cancer cell proliferation and migration
por: Tsachaki, Maria, et al.
Publicado: (2019)

Osr1 Regulates Macrophage-mediated Liver Inflammation in Nonalcoholic Fatty Liver Disease Progression
por: Liu, Lin, et al.
Publicado: (2022)

Fenretinide Causes Emphysema, Which Is Prevented by Sphingosine 1-Phoshate
por: Yasuo, Masanori, et al.
Publicado: (2013)

HSD17B7 gene in self‐renewal and oncogenicity of keratinocytes from Black versus White populations
por: Xu, Xiaoying, et al.
Publicado: (2021)

Neural expression and post-transcriptional dosage compensation of the steroid metabolic enzyme 17β-HSD type 4
por: London, Sarah E, et al.
Publicado: (2010)

Novel Benzothiazole-Based Ureas as 17β-HSD10 Inhibitors, A Potential Alzheimer’s Disease Treatment
por: Aitken, Laura, et al.
Publicado: (2019)

Synthesis of novel 13α-estrone derivatives by Sonogashira coupling as potential 17β-HSD1 inhibitors
por: Bacsa, Ildikó, et al.
Publicado: (2017)

Synthesis of 1,4-Biphenyl-triazole Derivatives as Possible 17β-HSD1 Inhibitors: An in Silico Study
por: Hernández-López, Hiram, et al.
Publicado: (2020)

Benzothiazolyl Ureas are Low Micromolar and Uncompetitive Inhibitors of 17β-HSD10 with Implications to Alzheimer’s Disease Treatment
por: Schmidt, Monika, et al.
Publicado: (2020)

Application of particle swarm optimization to understand the mechanism of action of allosteric inhibitors of the enzyme HSD17β13
por: Ford, Amy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lq698diakrdfe7cltsdrbhi7lg